this disclosure provides a system for improving survival of cells obtained by differentiating human embryonic stem cells , upon transplantation into a subject for regenerative medicine . transplanted cells that don &# 39 ; t survive normally send out signals that exacerbate the rejection response of the host , which in turn leads to further cell destruction . this invention helps allografts survive and benefit the subject by blocking this signal pathway .